Pharmasset Inc - FORM 10-K - EX-32.1 - CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 - November 23, 2010

Attached files

file filename
10-K - FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2010 - Pharmasset Incd10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) / RULE 15D-14(A) - Pharmasset Incdex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 - Pharmasset Incdex322.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) / RULE 15D-14(A) - Pharmasset Incdex311.htm
EX-23.1 - CONSENT OF GRANT THORNTON LLP - Pharmasset Incdex231.htm
EX-10.1 - COLLABORATION AGREEMENT - Pharmasset Incdex101.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K of Pharmasset, Inc. (the “Company”) for the year ended September 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, P. Schaefer Price, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 23, 2010

 

/s/    P. SCHAEFER PRICE

P. Schaefer Price

Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to Pharmasset, Inc. and will be retained by Pharmasset, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

Pharmasset Inc Reports